538 related articles for article (PubMed ID: 24409188)
1. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.
Yoshihara E; Masaki S; Matsuo Y; Chen Z; Tian H; Yodoi J
Front Immunol; 2014 Jan; 4():514. PubMed ID: 24409188
[TBL] [Abstract][Full Text] [Related]
2. Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions.
Sharma I; Yadav KS; Mugale MN
Pharmacol Res; 2022 Aug; 182():106292. PubMed ID: 35691540
[TBL] [Abstract][Full Text] [Related]
3. Redoxisome Update: TRX and TXNIP/TBP2-Dependent Regulation of NLRP-1/NLRP-3 Inflammasome.
Yoshihara E; Matsuo Y; Masaki S; Chen Z; Tian H; Masutani H; Yamauchi A; Hirota K; Yodoi J
Antioxid Redox Signal; 2024 Apr; 40(10-12):595-597. PubMed ID: 38386512
[TBL] [Abstract][Full Text] [Related]
4. TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis.
Yoshihara E
Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824669
[TBL] [Abstract][Full Text] [Related]
5. trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion.
Nivet-Antoine V; Cottart CH; Lemaréchal H; Vamy M; Margaill I; Beaudeux JL; Bonnefont-Rousselot D; Borderie D
Biochimie; 2010 Dec; 92(12):1766-71. PubMed ID: 20709139
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical Review.
Kar A; Paramasivam B; Jayakumar D; Swaroop AK; Jubie S
Curr Drug Res Rev; 2023; 15(3):228-240. PubMed ID: 36786139
[TBL] [Abstract][Full Text] [Related]
8. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein.
Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH
Nat Commun; 2014; 5():2958. PubMed ID: 24389582
[TBL] [Abstract][Full Text] [Related]
9. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells.
Myers JM; Antholine WE; Myers CR
Toxicology; 2008 Apr; 246(2-3):222-33. PubMed ID: 18328613
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species.
World C; Spindel ON; Berk BC
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1890-7. PubMed ID: 21636804
[TBL] [Abstract][Full Text] [Related]
11. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.
Spindel ON; World C; Berk BC
Antioxid Redox Signal; 2012 Mar; 16(6):587-96. PubMed ID: 21929372
[TBL] [Abstract][Full Text] [Related]
13. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.
Myers CR; Myers JM
Toxicology; 2009 Mar; 257(1-2):95-104. PubMed ID: 19135121
[TBL] [Abstract][Full Text] [Related]
14. The thioredoxin-1 inhibitor Txnip restrains effector T-cell and germinal center B-cell expansion.
Muri J; Thut H; Kopf M
Eur J Immunol; 2021 Jan; 51(1):115-124. PubMed ID: 32902872
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
Nasoohi S; Ismael S; Ishrat T
Mol Neurobiol; 2018 Oct; 55(10):7900-7920. PubMed ID: 29488135
[TBL] [Abstract][Full Text] [Related]
17. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.
Saxena G; Chen J; Shalev A
J Biol Chem; 2010 Feb; 285(6):3997-4005. PubMed ID: 19959470
[TBL] [Abstract][Full Text] [Related]
18. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions.
Hansen JM; Zhang H; Jones DP
Free Radic Biol Med; 2006 Jan; 40(1):138-45. PubMed ID: 16337887
[TBL] [Abstract][Full Text] [Related]
19. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.
Patwari P; Higgins LJ; Chutkow WA; Yoshioka J; Lee RT
J Biol Chem; 2006 Aug; 281(31):21884-21891. PubMed ID: 16766796
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]